91Âé¶¹

Study Enrollment


Your details will not be published or shared.

Clinical Trial

S1929,


Eligibility Criteria

  • Confirmed diagnosis of extensive stage small cell lung cancer (ES-SCLC) No prior immunotherapy for ES-SCLC No prior investigational treatment of ES-SCLC. Participants must be ? 18 years of age

Contact Information

    Angela Goebel

    (706) 721-2388

   agoebel@augusta.edu

RESEARCH. INNOVATION. DISCOVERY.